Radioimmunotherapy (RIT) Dose-Escalation Studies in Prostate Cancer Using Anti-Psma Antibody 177Lu-J591: RIT Alone and RIT in Combination With Docetaxel
doi 10.21236/ada512754
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2008
Authors
Publisher
Defense Technical Information Center